Literature DB >> 23888321

Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis.

Qiliang Cai1, Zhun Wang, Wei Zhang, Xuemei Guo, Zhiqun Shang, Ning Jiang, Jing Tian, Yuanjie Niu.   

Abstract

Genetic polymorphisms in glutathione S-transferases M1 (GSTM1) and T1 (GSTT1) genes have been widely reported and considered to have a significant effect on prostate cancer (PCa) risk, but the results are inconsistent. To evaluate the impact of the GSTM1 and GSTT1 polymorphism on PCa risk, we conducted a comprehensive meta-analysis based on 18 eligible studies. A total of 18 studies, including 7,119 subjects for GSTM1 and 6,454 subjects for GSTT1 between 1999 and 2012 were identified through researching MEDLINE, PubMed, Web of Science, EMBASE, Chinese National Knowledge Infrastructure database, and Chinese Biomedical Literature database. A meta-analysis was performed to obtain summary-estimated odd ratios and 95% confidence intervals of GSTM1 and GSTT1 polymorphisms for PCa, with attention to study quality and publication bias. Overall, there is a significant association between GSTM1 (odds ratio (OR) = 1.407, 95% confidence intervals (95% CI) = 1.147-1.727, I(2) = 73.2%, P = 0.001) genotypes and PCa susceptibility. Significant associations were also observed in subgroups of Caucasian populations (OR = 1.262, 95% CI = 1.055-1.511, I(2) = 48.7%, P = 0.011) and Asian populations (OR = 1.776, 95% CI = 1.134-2.781, I(2) = 83.4%, P = 0.012). However, no significant association was found (OR = 1.776, 95% CI = 1.134-2.781, P = 0.243) in African-American populations when stratified by ethnicity. While, there was no significant association seen between GSTT1 (OR = 1.003, 95% CI = 0.823-1.298, I(2) = 68.8%, P = 0.778) genotypes and PCa risk. However, no significant associations were observed in subgroups of Caucasian populations (OR = 1.086, 95% CI = 0.801-1.471, I(2) = 72.1%, P = 0.597) and Asian populations (OR = 0.961, 95% CI = 0.644-1.434, I(2) = 73.0%, P = 0.846), and similar result was found among African-American populations (OR = 0.802, 95% CI = 0.194-3.321, P = 0.761) when stratified by ethnicity. Our results suggest that the GSTM1 gene polymorphism contributes to PCa susceptibility, while GSTT1 gene polymorphism is not associated with PCa in our study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888321     DOI: 10.1007/s13277-013-1030-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.

Authors:  Zengnan Mo; Yong Gao; Yunfei Cao; Feng Gao; Lijuan Jian
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

2.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

3.  Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis.

Authors:  Christos Ntais; Anastasia Polycarpou; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

4.  Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.

Authors:  Rituraj Konwar; Parmeet Kaur Manchanda; Preeti Chaudhary; V Lakshma Nayak; Vishwajeet Singh; Hemant Kumar Bid
Journal:  Asian Pac J Cancer Prev       Date:  2010

5.  Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population.

Authors:  Hitender Thakur; Lipsy Gupta; Ranbir C Sobti; Ashok K Janmeja; Amlesh Seth; Sharwan K Singh
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

6.  Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?

Authors:  Zahra Ousati Ashtiani; Sayed-Mohammad Hasheminasab; Mohsen Ayati; Bareto Sabah Goulian; Mohammad Hossein Modarressi
Journal:  Pathol Oncol Res       Date:  2010-11-19       Impact factor: 3.201

7.  [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].

Authors:  Tong-yu Guan; Ming Li; Yan-qun Na
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2005-11-15

8.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

9.  Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms.

Authors:  Rui Medeiros; André Vasconcelos; Sandra Costa; Daniela Pinto; Paula Ferreira; Francisco Lobo; António Morais; Jorge Oliveira; Carlos Lopes
Journal:  Prostate       Date:  2004-03-01       Impact factor: 4.104

10.  Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies.

Authors:  Bingbing Wei; Zhuoqun Xu; You Zhou; Jun Ruan; Huan Cheng; Bo Xi; Ming Zhu; Ke Jin; Deqi Zhou; Qiang Hu; Qiang Wang; Zhirong Wang; Zhiqiang Yan; Feng Xuan; Xing Huang; Jian Zhang; Hongyi Zhou
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  9 in total

Review 1.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

2.  Glutathione S-transferase M1 null genotype related to poor prognosis of colorectal cancer.

Authors:  Shushan Yan; Zengfang Wang; Zengyan Wang; Quanhong Duan; Xiaochen Wang; Jun Li; Beicheng Sun
Journal:  Tumour Biol       Date:  2016-01-30

3.  Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.

Authors:  Qiliang Cai; Xinpeng Wang; Xiaodong Li; Rui Gong; Xuemei Guo; Yang Tang; Kuo Yang; Yuanjie Niu; Yan Zhao
Journal:  Oncotarget       Date:  2015-12-08

4.  GSTP1 A>G polymorphism and chemosensitivity of osteosarcoma: A meta-analysis.

Authors:  Wu Fengfeng; Ye Ruqing; Xu Juntao
Journal:  Open Med (Wars)       Date:  2016-04-18

5.  Prostate cancer and glutathione S-transferase deletions.

Authors:  Saima Shakil Malik; Nosheen Masood; Azra Yasmin
Journal:  EXCLI J       Date:  2015-09-21       Impact factor: 4.068

6.  The Genetic Architecture of Murine Glutathione Transferases.

Authors:  Lu Lu; Ashutosh K Pandey; M Trevor Houseal; Megan K Mulligan
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

7.  Polymorphism of glutathione S-transferase in the population of Polish patients with carcinoma of the prostate.

Authors:  Joanna M Drozdz-Afelt; Beata Koim-Puchowska; Grzegorz Klosowski; Piotr Kaminski
Journal:  Environ Sci Pollut Res Int       Date:  2020-03-24       Impact factor: 4.223

8.  Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding.

Authors:  Angela Galardi; Marta Colletti; Chiara Lavarello; Virginia Di Paolo; Paolo Mascio; Ida Russo; Raffaele Cozza; Antonino Romanzo; Paola Valente; Rita De Vito; Luisa Pascucci; Hector Peinado; Angel M Carcaboso; Andrea Petretto; Franco Locatelli; Angela Di Giannatale
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

9.  GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population

Authors:  Maroua Benabdelkrim; Omar Djeffal; Hajira Berredjem
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.